GI
XTNT icon

Gradient Investments’s Xtant Medical Holdings XTNT Stock Holding History

Gradient Investments’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-83
Closed -$3K – 794
2015
Q4 		$3K Buy
+83
New +$2.92K ﹤0.01% 562
2015
Q2 		– Sell
-83
Closed -$4K – 729
2015
Q1 		$4K Hold
83
– – ﹤0.01% 497
2014
Q4 		$3K Hold
83
– – ﹤0.01% 468
2014
Q3 		$4K Hold
83
– – ﹤0.01% 388
2014
Q2 		$7K Hold
83
– – ﹤0.01% 391
2014
Q1 		$8K Hold
83
– – ﹤0.01% 363
2013
Q4 		$5K Hold
83
– – ﹤0.01% 441
2013
Q3 		$7K Hold
83
– – ﹤0.01% 319
2013
Q2 		$4K Buy
+83
New +$6.86K ﹤0.01% 329

Other funds holding XTNT

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gradient Investments's XTNT Position: Q1 2016 in Review

Gradient Investments sold out of Xtant Medical Holdings (XTNT) in Q1 2016, closing a stake of 83 shares — an estimated $3K sold.

Gradient Investments first reported a position in XTNT in Q2 2013 and held it in 9 quarters. The position peaked at $8K in Q1 2014. 18 funds tracked by Wall St. Rank hold XTNT as of Q1 2016.

  • Gradient Investments reported no remaining Xtant Medical Holdings position as of Q1 2016 after selling out during the quarter.
  • Gradient Investments sold 83 Xtant Medical Holdings shares in Q1 2016, an estimated $3K.
  • Gradient Investments first reported a position in Xtant Medical Holdings in Q2 2013 and held it in 9 quarters.
  • Gradient Investments's Xtant Medical Holdings position peaked at $8K in Q1 2014.
  • 18 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2016.

Based on Gradient Investments's 13F filing for Q1 2016, filed 13 Apr 2016.